UNICOC
Bogotá, Colombia
NCT Number: NCT01529879
Integration success rates and the preservation of crestal bone will be higher for the experimental device than for the control implants.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bogotá, Colombia
In this study patients are randomized to receive either the experimental implant system or the control Nanotite Certain Tapered (standard abutment connection) and assessed for integration success measured by lack of implant mobility and lack of bone loss obtained at various study time points
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
New abutment connection implant
Other names: Osseotite Endosseous dental implant
Nanotite Certain Tapered (standard abutment connection) implant
Other names: Nanotite endosseous dental implant
Time frame: 2 years
Crestal bone regression (amount of bone loss measured) and equivalence in integration success (implant mobility)
ZimVie
Industry
A Prospective Randomized-Controlled Evaluation of an Implant System With a Novel Abutment Attachment Design for the Preservation of Crestal Bone
Acronym: Polaris
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00728754
Partial Edentulism, Stomatognathic Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00723944
Partial Edentulism, Stomatognathic Diseases
Berlin, Germany
View Trial DetailsNCT00728962
Partial Edentulism, Stomatognathic Diseases
Los Angeles, California, United States
View Trial DetailsNCT00726063
Partial Edentulism, Stomatognathic Diseases
Birmingham, Alabama, United States
View Trial Details